Core Viewpoint - SanDa Membrane (688101.SH) announces its first special dividend since its listing, indicating stable operations and a commitment to shareholder returns [1][2]. Financial Performance - In 2023 and 2024, SanDa Membrane achieved revenues of 1.451 billion yuan and 1.391 billion yuan, with year-on-year changes of 15.20% and -4.11% respectively. Net profit attributable to shareholders was 254 million yuan and 315 million yuan, showing growth rates of 16.55% and 23.97% [1]. - Historical data shows that from 2019 to 2023, the company's net profit exceeded 200 million yuan annually, with 2024 marking the first time it surpassed 300 million yuan, reflecting rapid growth [2]. - For the first three quarters of 2025, the company reported revenues of 1.156 billion yuan, a year-on-year increase of 11%, and a net profit of 298 million yuan, up 40.20% from the previous year [2]. - The operating cash flow for the first three quarters of 2025 was 147 million yuan, representing a significant increase of 133.82% year-on-year [2]. R&D Investment - SanDa Membrane has consistently increased its R&D investment since its establishment in 1996. In 2019, R&D expenditure was approximately 39.42 million yuan, rising to 66.85 million yuan by 2024. For the first three quarters of 2025, R&D investment was 50.33 million yuan, reflecting a year-on-year growth of 14.27% [2]. Financial Health - As of September 2025, SanDa Membrane's debt-to-asset ratio stood at 28.59%, with total cash and financial assets amounting to 1.665 billion yuan, while interest-bearing debt was only 58 million yuan [3].
三达膜盈利连增拟特别分红6972万元 前三季经营现金流净额1.47亿元